当前位置: 首页 > 详情页

The Myocardial Protection of Polarizing Cardioplegia Combined With Delta-Opioid Receptor Agonist in Swine

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiopulm Bypass, Beijing 100029, Peoples R China; [2]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China
出处:
ISSN:

摘要:
Background. The purpose of this study was to determine whether polarized arrest using adenosine/lidocaine cold crystalloid cardioplegia in combination with the hibernation inductor delta-opioid receptor agonist pentazocine would give satisfactory myocardial protection rather than using depolarized supranormal potassium cardioplegia, supranormal potassium cardioplegia with pentazocine, or adenosine/lidocaine cardioplegia. Methods. Twenty pigs were randomly divided into four groups (n = 5 each) to receive the four types of cold crystalloid cardioplegia with an aortic cross-clamp time of 1 hour. Hemodynamic data were continuously measured, as was the left ventricular end-diastolic pressure (LVEDP), left ventricular end-systolic pressure (LVESP), plus or minus derivative of change in diastolic pressure over time (+/- dp/dt), cardiac output, pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac troponin I, and left ventricular ultrastructure. Results. Both the adenosine/lidocaine/pentazocine group and the adenosine/lidocaine group got significantly better results than the hyperkalemic and hyperkalemic pentazocine groups in improving hemodynamic values, pulmonary capillary wedge pressure, LVEDP, LVESP, +/- dp/dt, cardiac output, cardiac troponin I values, and left ventricular ultrastructure. There were no statistical differences between the adenosine/lidocaine/pentazocine group and the adenosine/lidocaine group at 1 hour after cross-clamp removal; but at 2 hours after crossclamp removal, the adenosine/lidocaine/pentazocine group stands out (LVEDP 3.3 +/- 0.5, LVESP 122.5 +/- 18.9, +dp/dt 2.9 +/- 0.1, -dp/dt 2.0 +/- 0.6, cardiac output 2.6 +/- 0.4, and troponin I 4.9 +/- 0.5), with significant differences from the adenosine/lidocaine group (LVEDP 5.8 +/- 1.0, LVESP 98.5 +/- 10.1, +dp/dt 2.5 +/- 0.2, -dp/dt 1.0 +/- 0.2, cardiac output 2.2 +/- 0.2, troponin I 8.2 +/- 0.8; p < 0.05). The defibrillation rate was largely decreased after the cross-clamp was released in the group containing pentazocine in cardioplegia. Conclusions. Adenosine/lidocaine/pentazocine cold crystalloid cardioplegia gave satisfactory cardiac arrest and better myocardial protection than the other three groups, especially with regard to improving prolonged postoperative cardiac function.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2010]版:
大类 | 3 区 医学
小类 | 2 区 外科 3 区 心脏和心血管系统 3 区 呼吸系统
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 呼吸系统 2 区 外科 3 区 心脏和心血管系统
JCR分区:
出版当年[2009]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Q1 SURGERY Q1 RESPIRATORY SYSTEM
最新[2023]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Q1 RESPIRATORY SYSTEM Q1 SURGERY

影响因子: 最新[2023版] 最新五年平均 出版当年[2009版] 出版当年五年平均 出版前一年[2008版] 出版后一年[2010版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiopulm Bypass, Beijing 100029, Peoples R China; [2]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiopulm Bypass, Beijing 100029, Peoples R China; [2]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院